41294 (2025). Camilla Belich to the Associate Minister of Health

41294 (2025). Camilla Belich to the Associate Minister of Health: How many board fee reviews, if any, have been completed for entities under their responsibility, if any, in the past 12 months, and what was the total cost of those fee changes, broken down by entity?

Hon David Seymour: Pharmac Board fees were reviewed in December 2024 and were reclassified from a Group 3a Level 3 body to a Group 3a Level 2 body. The Chair’s fee increased from $48,000 pa to $66,000 pa, the Deputy Chair from $30,000 pa to $41,000 pa, and members from $24,000 pa to $33,000 pa. Board fees are met from within Pharmac’s current baseline operational funding.